NCT04543045

Brief Summary

The study aims to explore the experience of patients with Head and Neck Cancer, who are preparing for and/or completed radiotherapy treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 9, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

May 5, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

March 14, 2023

Status Verified

March 1, 2023

Enrollment Period

2.3 years

First QC Date

July 30, 2020

Last Update Submit

March 13, 2023

Conditions

Keywords

patient experienceclaustrophobiaradiotherapyradiotherapy mouldsradiotherapy masks

Outcome Measures

Primary Outcomes (1)

  • Patient experience

    Interviews will be used to generate themes that capture the patients experience. These themes are the primary outcome.There are no units of measurement or data collection tools only an interview schedule.

    within 6 weeks of using a mask

Secondary Outcomes (1)

  • potential items for a questionnaire

    2 months after completing or partially completing radiotherapy.

Study Arms (2)

Stage 1

20 patients will be interviewed once, which will be approximately 60 minutes in duration. The interviews will be audio recorded.

Other: not an intervention

Stage 2

Five patients who participated in stage 1 will take part in a cognitive interview, which will be approximately 60 minutes in duration.The interviews will be audio recorded.

Other: not an intervention

Interventions

not an intervention

Stage 1Stage 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Range of patients who have completed or partially completed radiotherapy treatment utilising a mask. This will include a range of patients (i) those who's records indicate, or patients report that they experienced severe difficulties tolerating the mask, (ii) those who could not complete the full course of radiotherapy; and (iii) those who experienced no difficulties at all.

You may qualify if:

  • Aged over 18 (no upper age limit)
  • Completed or partially completed radiotherapy treatment utilising a mask ≥ 6 weeks previous to study entry

You may not qualify if:

  • Unable to understand and communicate in the English language
  • Unable to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Christie NHS Foundation

Manchester, m20 4bx, United Kingdom

RECRUITING

MeSH Terms

Conditions

NeoplasmsHead and Neck NeoplasmsAnxiety DisordersClaustrophobia

Condition Hierarchy (Ancestors)

Neoplasms by SiteMental DisordersPhobic Disorders

Study Officials

  • Jacqui Stringer

    The Christie NHS Foundation Trust

    STUDY CHAIR

Central Study Contacts

Daisy Hopper

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2020

First Posted

September 9, 2020

Study Start

May 5, 2021

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

March 14, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations